Page 12«..11121314..2030..»

Category Archives: MS Treatment

Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid – no clear evidence of positive disease modifying effects – DocWire…

Posted: Published on May 12th, 2021

This article was originally published here Neurol Res Pract. Continue reading

Posted in MS Treatment | Comments Off on Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid – no clear evidence of positive disease modifying effects – DocWire…

South Jersey MS Center Now Offering TMS Therapy For Those With Chronic Treatment-Resistant Illnesses – WFMZ Allentown

Posted: Published on May 12th, 2021

SCOTCH PLAINS, N.J., May 11, 2021 /PRNewswire-PRWeb/ -- Dr. Steven M. Bromley, Dr Continue reading

Posted in MS Treatment | Comments Off on South Jersey MS Center Now Offering TMS Therapy For Those With Chronic Treatment-Resistant Illnesses – WFMZ Allentown

Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden…

Posted: Published on May 12th, 2021

This article was originally published here J Med Econ. 2021 May 8:1 Continue reading

Posted in MS Treatment | Comments Off on Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden…

Treatment and decision-making process in multiple sclerosis | PPA – Dove Medical Press

Posted: Published on May 12th, 2021

Introduction Multiple sclerosis (MS) is a chronic degenerative disease of the central nervous system affecting 700,000 persons in Europe. Continue reading

Posted in MS Treatment | Comments Off on Treatment and decision-making process in multiple sclerosis | PPA – Dove Medical Press

Autobahn Therapeutics Acquires Clinical-Stage FAAH Inhibitor from Astellas, Strengthening its Brain Targeting Chemistry Platform – Business Wire

Posted: Published on May 12th, 2021

SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced it has acquired global rights to ASP3652, a novel oral peripherally restricted fatty acid amide hydrolase (FAAH) inhibitor from Astellas Pharma Inc. ASP3652 complements Autobahns brain-targeting chemistry platform, which uses FAAH-mediated prodrug conversion to enable delivery of small molecules across the blood brain barrier. Peripheral blockade of FAAH activity further improves selective brain delivery of Autobahns compounds and enhances the ability to tailor a drugs biodistribution to match the pathophysiology of various disorders. Continue reading

Posted in MS Treatment | Comments Off on Autobahn Therapeutics Acquires Clinical-Stage FAAH Inhibitor from Astellas, Strengthening its Brain Targeting Chemistry Platform – Business Wire

Workington mum needs 50,000 for vital MS treatment | News and Star – News & Star

Posted: Published on May 12th, 2021

A mother from Workington is appealing for people to help her raise funds for life-changing surgery in Mexico. Brogan Johnston, 26, has set up a go fund me page to try and raise the 50,000 she needs to receive treatment for Multiple Sclerosis after she was diagnosed earlier this year Continue reading

Posted in MS Treatment | Comments Off on Workington mum needs 50,000 for vital MS treatment | News and Star – News & Star

SCYNEXIS Appoints Accomplished Commercial Executive Christine Coyne as Chief Commercial Officer to Lead the Brexafemme Launch – GlobeNewswire

Posted: Published on May 12th, 2021

JERSEY CITY, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. Continue reading

Posted in MS Treatment | Comments Off on SCYNEXIS Appoints Accomplished Commercial Executive Christine Coyne as Chief Commercial Officer to Lead the Brexafemme Launch – GlobeNewswire

Pandemic gets the Michael Lewis treatment – Business Standard

Posted: Published on May 12th, 2021

Theres nobody Michael Lewis likes better than a hero who gives a defiant middle finger to the conventional wisdom: The short-seller who bets against a soaring mortgage market; the equities trader who insists that the stock exchange is rigged. And then theres Mr Lewis himself, who has made his own name and fortune by writing against expectations, taking arcane subjects that most of his mega-readership might know next to nothing about and skilfully unfurling their intricacies in all of their dramatic glory. Continue reading

Posted in MS Treatment | Comments Off on Pandemic gets the Michael Lewis treatment – Business Standard

CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study – DocWire News

Posted: Published on May 12th, 2021

This article was originally published here Brain Pathol. Continue reading

Posted in MS Treatment | Comments Off on CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study – DocWire News

TG Therapeutics Provides Business Update and Reports First Quarter 2021 Financial ResultsConference call to be held today, Monday, May 10, 2021 at…

Posted: Published on May 12th, 2021

NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the first quarter ending March 31, 2021 and recent company developments, along with a business outlook for 2021. Michael S. Continue reading

Posted in MS Treatment | Comments Off on TG Therapeutics Provides Business Update and Reports First Quarter 2021 Financial ResultsConference call to be held today, Monday, May 10, 2021 at…

Page 12«..11121314..2030..»